(4S,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((S)-1-hydroxyethyl)-4-methyl-7-oxo-N-(4-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S)-5,8,11,14-tetrakis((1H-indol-3-yl)methyl)-17,20,23,26,29-pentakis(3-guanidinopropyl)-3,6,9,12,15,18,21,24,27,30-decaoxo-1,4,7,10,13,16,19,22,25,28-decaazacyclotriacontan-2-yl)butyl)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxamide

ID: ALA5201645

Chembl Id: CHEMBL5201645

PubChem CID: 168292209

Max Phase: Preclinical

Molecular Formula: C97H135N33O14S

Molecular Weight: 2019.43

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](O)[C@H]1C(=O)N2C(C(=O)NCCCC[C@@H]3NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC(=O)[C@H](Cc4c[nH]c5ccccc45)NC3=O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@@H](C)[C@H]12

Standard InChI:  InChI=1S/C97H135N33O14S/c1-50-77-76(51(2)131)92(144)130(77)78(79(50)145-56-44-75(118-49-56)91(143)129(3)4)90(142)108-34-14-13-28-65-85(137)125-72(41-53-46-115-62-25-10-6-21-58(53)62)87(139)127-74(43-55-48-117-64-27-12-8-23-60(55)64)89(141)128-73(42-54-47-116-63-26-11-7-22-59(54)63)88(140)126-71(40-52-45-114-61-24-9-5-20-57(52)61)86(138)124-70(33-19-39-113-97(106)107)84(136)123-69(32-18-38-112-96(104)105)83(135)122-68(31-17-37-111-95(102)103)82(134)121-67(30-16-36-110-94(100)101)81(133)120-66(80(132)119-65)29-15-35-109-93(98)99/h5-12,20-27,45-48,50-51,56,65-77,114-118,131H,13-19,28-44,49H2,1-4H3,(H,108,142)(H,119,132)(H,120,133)(H,121,134)(H,122,135)(H,123,136)(H,124,138)(H,125,137)(H,126,140)(H,127,139)(H,128,141)(H4,98,99,109)(H4,100,101,110)(H4,102,103,111)(H4,104,105,112)(H4,106,107,113)/t50-,51-,56-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76+,77+/m0/s1

Standard InChI Key:  NMEMXUFUEJODFW-ZHGSGXHFSA-N

Alternative Forms

  1. Parent:

    ALA5201645

    ---

Associated Targets(Human)

HepaRG (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cell membrane (1233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 2019.43Molecular Weight (Monoisotopic): 2018.0587AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Mohammed EHM, Lohan S, Tiwari RK, Parang K..  (2022)  Amphiphilic cyclic peptide [W4KR5]-Antibiotics combinations as broad-spectrum antimicrobial agents.,  235  [PMID:35339840] [10.1016/j.ejmech.2022.114278]

Source